Position in NTRA
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$5,604,319
+$4,613,388 QoQ
Shares Held
28,023
+355.2% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $30,838,073 across 12 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
16,330 | $8,596,765 | |
| 2 | GH |
Guardant Health, Inc.
|
52,547 | $7,883,626 | |
| 3 | ILMN |
Illumina, Inc.
|
18,655 | $3,280,108 | |
| 4 | ADPT |
Adaptive Biotechnologies Corp
|
33,784 | $2,898,688 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
10,950 | $2,115,759 | |
| 6 | WGS |
GeneDx Holdings Corp.
|
27,521 | $1,889,316 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
2,669 | $1,338,129 | |
| 8 | LH |
Labcorp Holdings Inc.
|
4,074 | $1,140,720 |
All Filings in NTRA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,604,319 | 28,023 | Shares | Sole | 2026-04-27 | |
| 2025-09-30 | $990,931 | 6,156 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,691,089 | 10,010 | Shares | Sole | 2025-08-01 | |
| 2024-12-31 | $4,930,095 | 31,144 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,267,468 | 9,984 | Shares | Sole | 2024-11-15 | |
| 2024-03-31 | $1,592,958 | 17,417 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $793,962 | 12,675 | Shares | Sole | 2024-02-13 | |
| 2023-03-31 | $1,410,929 | 25,413 | Shares | Sole | 2023-05-09 | |
| 2021-06-30 | $1,148,128 | 10,113 | Shares | Sole | 2021-08-26 | |
| 2020-12-31 | $257,955 | 2,592 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||